The role of peroxiredoxin II in chemoresistance of breast cancer cells

Tieli Wang,1 Anthony Joseph Gomez Diaz,1 Yun Yen2 1Department of Chemistry and Biochemistry, California State University Dominguez Hills, Carson, CA, USA; 2Department of Clinical and Molecular Pharmacology, Beckman Research Institute of City of Hope National Medical Center, Duarte, CA, USA Abstrac...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wang T, Diaz AJG, Yen Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/fce47c0a37004c25abbce92930409636
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fce47c0a37004c25abbce92930409636
record_format	dspace
spelling	oai:doaj.org-article:fce47c0a37004c25abbce929304096362021-12-02T07:45:49ZThe role of peroxiredoxin II in chemoresistance of breast cancer cells1179-1314https://doaj.org/article/fce47c0a37004c25abbce929304096362014-05-01T00:00:00Zhttp://www.dovepress.com/the-role-of-peroxiredoxin-ii-in-chemoresistance-of-breast-cancer-cells-a16966https://doaj.org/toc/1179-1314 Tieli Wang,1 Anthony Joseph Gomez Diaz,1 Yun Yen2 1Department of Chemistry and Biochemistry, California State University Dominguez Hills, Carson, CA, USA; 2Department of Clinical and Molecular Pharmacology, Beckman Research Institute of City of Hope National Medical Center, Duarte, CA, USA Abstract: Peroxiredoxin (Prx)II belongs to a family of redox-active proteins that use redox-sensitive cysteine in the active site to reduce peroxides. PrxII is induced by various oxidative stimuli and plays an important protective role against oxidative radical damage by reactive oxygen species. PrxII expression levels are correlated with resistance to radiation therapy or certain anti-cancer drugs in radioresistant breast cancer cells, glioblastomas, and head and neck cancer cells as well as in tissue isolated from head and neck patients who do not respond to radiation therapy. Small interfering RNA (siRNA) that inhibits the PrxII gene expression has been shown to partially reverse the radioresistant phenotype in radiation resistant breast cancer cells and sensitizes glioma cells to oxidative stress, highlighting the potential clinical importance of PrxII in radiation resistance in cancer. This article focuses on the role that PrxII may play in chemoresistant breast cancer cells. Keywords: siRNA, redox, cysteine disulfide bridges, targeted therapy, reactive oxygen speciesWang TDiaz AJGYen YDove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol 2014, Iss default, Pp 73-80 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Wang T Diaz AJG Yen Y The role of peroxiredoxin II in chemoresistance of breast cancer cells
description	Tieli Wang,1 Anthony Joseph Gomez Diaz,1 Yun Yen2 1Department of Chemistry and Biochemistry, California State University Dominguez Hills, Carson, CA, USA; 2Department of Clinical and Molecular Pharmacology, Beckman Research Institute of City of Hope National Medical Center, Duarte, CA, USA Abstract: Peroxiredoxin (Prx)II belongs to a family of redox-active proteins that use redox-sensitive cysteine in the active site to reduce peroxides. PrxII is induced by various oxidative stimuli and plays an important protective role against oxidative radical damage by reactive oxygen species. PrxII expression levels are correlated with resistance to radiation therapy or certain anti-cancer drugs in radioresistant breast cancer cells, glioblastomas, and head and neck cancer cells as well as in tissue isolated from head and neck patients who do not respond to radiation therapy. Small interfering RNA (siRNA) that inhibits the PrxII gene expression has been shown to partially reverse the radioresistant phenotype in radiation resistant breast cancer cells and sensitizes glioma cells to oxidative stress, highlighting the potential clinical importance of PrxII in radiation resistance in cancer. This article focuses on the role that PrxII may play in chemoresistant breast cancer cells. Keywords: siRNA, redox, cysteine disulfide bridges, targeted therapy, reactive oxygen species
format	article
author	Wang T Diaz AJG Yen Y
author_facet	Wang T Diaz AJG Yen Y
author_sort	Wang T
title	The role of peroxiredoxin II in chemoresistance of breast cancer cells
title_short	The role of peroxiredoxin II in chemoresistance of breast cancer cells
title_full	The role of peroxiredoxin II in chemoresistance of breast cancer cells
title_fullStr	The role of peroxiredoxin II in chemoresistance of breast cancer cells
title_full_unstemmed	The role of peroxiredoxin II in chemoresistance of breast cancer cells
title_sort	role of peroxiredoxin ii in chemoresistance of breast cancer cells
publisher	Dove Medical Press
publishDate	2014
url	https://doaj.org/article/fce47c0a37004c25abbce92930409636
work_keys_str_mv	AT wangt theroleofperoxiredoxiniiinchemoresistanceofbreastcancercells AT diazajg theroleofperoxiredoxiniiinchemoresistanceofbreastcancercells AT yeny theroleofperoxiredoxiniiinchemoresistanceofbreastcancercells AT wangt roleofperoxiredoxiniiinchemoresistanceofbreastcancercells AT diazajg roleofperoxiredoxiniiinchemoresistanceofbreastcancercells AT yeny roleofperoxiredoxiniiinchemoresistanceofbreastcancercells
_version_	1718399196839542784

The role of peroxiredoxin II in chemoresistance of breast cancer cells

Ejemplares similares